Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJun 03, 2024
DataAggregated Company Financials
Companies5
- 7D1.8%
- 3M-10.2%
- 1Y-45.6%
- YTDn/a
The Drug Retail industry is up 1.8% in the last week, with Alibaba Health Information Technology up 9.8%. In the same time, JD Health International was down 6.0%. In contrast, the industry has lost 46% in the last 12 months. Looking forward, earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 03 Jun 2024 | HK$155.3b | HK$102.4b | HK$2.4b | 45.7x | 64.8x | 1.5x |
| Wed, 01 May 2024 | HK$152.9b | HK$103.7b | HK$2.3b | 45.7x | 65.7x | 1.5x |
| Fri, 29 Mar 2024 | HK$158.8b | HK$103.6b | HK$13.7m | 48x | 11570.9x | 1.5x |
| Sun, 25 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,456,103,459.27 | 58.2x | -120.8x | 1.7x |
| Tue, 23 Jan 2024 | HK$154.5b | HK$105.0b | -HK$1,455,179,765.00 | 49.9x | -106.2x | 1.5x |
| Thu, 21 Dec 2023 | HK$201.3b | HK$105.7b | -HK$1,464,286,842.00 | 62.6x | -137.4x | 1.9x |
| Sat, 18 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,798,457.00 | 86.2x | -120.6x | 2.1x |
| Mon, 16 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Wed, 13 Sep 2023 | HK$233.4b | HK$102.6b | -HK$1,679,619,096.00 | 84.4x | -139x | 2.3x |
| Fri, 11 Aug 2023 | HK$280.3b | HK$95.9b | -HK$4,161,689,179.00 | 131.4x | -67.3x | 2.9x |
| Sun, 09 Jul 2023 | HK$255.0b | HK$95.8b | -HK$4,157,683,426.00 | 109.3x | -61.3x | 2.7x |
| Tue, 06 Jun 2023 | HK$271.5b | HK$97.0b | -HK$4,291,862,143.00 | 242.5x | -63.3x | 2.8x |
| Thu, 04 May 2023 | HK$298.3b | HK$95.5b | -HK$4,889,171,888.00 | 448x | -61x | 3.1x |
| Sat, 01 Apr 2023 | HK$317.6b | HK$96.0b | -HK$4,914,234,350.00 | 478.9x | -64.6x | 3.3x |
Price to Earnings Ratio
-116.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 64.8x which is lower than its 3-year average PE of 139x.
- The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.5% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -2.29% | |
| Consumer Staples | -2.63% | |
| Food and Staples Retail | 1.06% | |
| Drug Retail | 1.82% | |
| Big Box Super Stores | 5.02% | |
| Food Distributors | -1.55% | |
| Food Retail | -2.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 241 Alibaba Health Information Technology | HK$3.37 | 9.8% +HK$4.8b | -31.6% | PE56.8x |